These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17105930)

  • 21. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of dopamine injected into the lateral brain ventricle on flash visual evoked potential (FVEP) after prenatal intoxication with cadmium].
    Herba E; Pojda-Wilczek D; Pojda SM; Plech A; Szkilnik R
    Klin Oczna; 2000; 102(6):405-8. PubMed ID: 11392798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dopamine agonists in Parkinson's disease: an update.
    Bonuccelli U; Pavese N
    Expert Rev Neurother; 2007 Oct; 7(10):1391-9. PubMed ID: 17939774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse.
    Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is dopaminergic therapy immunologically rejuvinating? Increased interferon-gamma production with the dopaminergic agent lisuride].
    Poehlau D; Baier JE; Kovacs S; Gallati H; Suchy I; Will C; Schmutz T; Neumann HA; Przuntek H
    Fortschr Med; 1994 Apr; 112(12):174-6. PubMed ID: 8200605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.
    Jaunarajs KL; Dupre KB; Steiniger A; Klioueva A; Moore A; Kelly C; Bishop C
    Neuroreport; 2009 Sep; 20(14):1265-9. PubMed ID: 19633584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lisuride reduces intravenous cocaine self-administration in rats.
    Pulvirenti L; Koob GF
    Pharmacol Biochem Behav; 1994 Apr; 47(4):819-22. PubMed ID: 8029249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.
    Picconi B; Paillé V; Ghiglieri V; Bagetta V; Barone I; Lindgren HS; Bernardi G; Angela Cenci M; Calabresi P
    Neurobiol Dis; 2008 Feb; 29(2):327-35. PubMed ID: 17997101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
    Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
    Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine tegmental nucleus.
    Di Giovanni G; Shi WX
    Synapse; 2009 Aug; 63(8):673-80. PubMed ID: 19360852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intranasally applied dopamine on behavioral asymmetries in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal tract.
    Pum ME; Schäble S; Harooni HE; Topic B; De Souza Silva MA; Li JS; Huston JP; Mattern C
    Neuroscience; 2009 Aug; 162(1):174-83. PubMed ID: 19401223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
    Fulceri F; Biagioni F; Lenzi P; Falleni A; Gesi M; Ruggieri S; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():344-8. PubMed ID: 17105931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S18-23. PubMed ID: 17702631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D1 receptor stimulation of the nucleus accumbens or the medial preoptic area promotes the onset of maternal behavior in pregnancy-terminated rats.
    Stolzenberg DS; McKenna JB; Keough S; Hancock R; Numan MJ; Numan M
    Behav Neurosci; 2007 Oct; 121(5):907-19. PubMed ID: 17907823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats.
    Rose S; Ramsay Croft N; Jenner P
    Brain Res; 2007 Feb; 1133(1):110-4. PubMed ID: 17196564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.